Zantac on sale over counter

Glaxo has won approval for over-the-counter sales of its best-selling drug, Zantac, in Britain. The drug, which relieves the symptoms of heartburn and dyspepsia, will be on sale within the first quarter of this year, marketed through Glaxo's alli ance with Warner Wellcome.

The company is seeking regulatory approval for over-the-counter sales of the drug in other countries, including the US.

Busin

Comments